Invention Grant
- Patent Title: Antibody-drug conjugates
-
Application No.: US15812811Application Date: 2017-11-14
-
Publication No.: US11135306B2Publication Date: 2021-10-05
- Inventor: Nan-Horng Lin , Charng-Sheng Tsai , Ting-Chun Hung , Hong-Yang Chuang
- Applicant: CHO Pharma Inc.
- Applicant Address: TW Taipei
- Assignee: CHO Pharma Inc.
- Current Assignee: CHO Pharma Inc.
- Current Assignee Address: TW Taipei
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61K47/61 ; A61K47/54 ; A61K31/40 ; A61P35/00 ; A61K38/08 ; C07K16/32

Abstract:
An antibody-drug conjugate (ADC) has a structure represented by Formula (I): [D2-L2-Cn2yG2-Ab-Sg1G1-L1-D1]x Formula (I) or a pharmaceutically acceptable salt thereof, wherein Ab is an antibody without glycans (i.e., the protein portion of an antibody); G1 and G2 are glycan moieties, which may be the same or different; Cn1 and Cn2 are conjugation moieties, which may be the same or different; L1 and L2 are linker moieties, which may be the same or different; D1 and D2 are drug units which may be the same or different; and x and y are independently an integer from 0 to 8, provided that x+y≠0.
Public/Granted literature
- US20180133340A1 ANTIBODY-DRUG CONJUGATES Public/Granted day:2018-05-17
Information query
IPC分类: